Introduction: The clinical utility of metabolic dysfunction-associated steatotic liver disease (MASLD) in predicting subsequent subclinical cardiovascular damages in pediatric population remains poorly understood.
Methods: Data on 1,161 Chinese children aged 10-15 years were used to assess the longitudinal associations of MASLD with subsequent subclinical cardiovascular measures.
Results: Compared with relatively healthy children, children with MASLD had abnormal vascular and cardiac structures, along with reduced cardiac diastolic function at the 2-year follow-up. In addition, children with MASLD had a significantly increased risk of high carotid intima-media thickness and left ventricular hypertrophy.
Discussion: These findings support the clinical utility of MASLD in predicting the development of subclinical cardiovascular damages in childhood.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.14309/ajg.0000000000003278 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!